- Pin
- #Over 100 Companies Hold Over 830,000 BTC#
According to reports as of June 19, more than 100 companies collectively hold over 830,000 BTC, worth about $86.476 billion.
💬 Do you think Bitcoin will become a new norm for corporate asset allocation? How might this impact Bitcoin’s price? What’s your recent BTC trading strategy? Post to share your price predictions, market analysis, and strategies with us using the topic tag!
🎁 Meanwhile, Gate’s BTC Staking event is in full swing! Simply stake your BTC and earn up to 3% APY. Click the link to start staking and enjoy your earnings: https://ww - 🏁 Gate Red Bull Racing Tour 2025 In Full Swing!
Up to now, the total trading volume exceeded $2 billion, with top trader trading volume nearing $200 million
Join the race now & fuel your trades for real-world rewards:
✅ 5,000 GT Prize Pool
✅ VIP Seat at an F1 Grand Prix
✅ Futures Vouchers for New Signups
Start your engines & trade fast
Top the leaderboards. The Race is ON!
👉 Go Now: www.gate.com/competition/f1rb/s1
#GateRedBullRacingTour# - 📢 Gate releases its latest Reserve Audit Report!
💰 Total reserves: $10.453B
🟢 Excess reserves: $1.96B — ensuring full coverage and extra security for user assets.
Gate continues to uphold 100% proof-of-reserves and full transparency.
🔗 Read the full report: https://www.gate.com/zh/announcements/article/45617
Parataxis Holdings launched a Bitcoin-based native fund management platform in the country through the acquisition of the South Korean listed company Bridge Bio.
According to Techub News, Bitcoin investment company Parataxis Holdings LLC announced that it has reached a final investment agreement of 25 billion KRW with Bridge Biotherapeutics, Inc., which grants it control of the latter. After the transaction is completed, Bridge Biotherapeutics will be renamed Parataxis Korea and will continue to be listed on the KOSDAQ market in South Korea.
This transaction will create a Bitcoin-based native fund management platform in the South Korean public market, supported by institutional investors with rich experience in digital asset investment. As part of the transaction, Edward Chin, founder and CEO of Parataxis Holdings and co-founder and CEO of Parataxis Capital, will join the company's board of directors. Andrew Kim, partner at Parataxis Capital, will serve as the company's CEO and join the board. James Jungkue Lee, co-founder of Bridge Bio, will continue to lead the core biotechnology business and serve as a member of the company's board.